Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
Jul 31, 2026, 11:42 AM EST
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $2.9 million as of July 31, 2026. Its market cap has decreased by -14.29% in one year.
Market Cap
2.90M
Enterprise Value
n/a
Revenue
46.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 2.90M, a decrease of -97.29%. That is a compound annual growth rate of -18.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.66M | 83.33% |
| Dec 31, 2025 | 1.45M | -68.42% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Institute of Biomedical Research | 3.30M |
| Eastgate Biotech | 3.17M |
| Vaccinex | 3.16M |
| Pacific Software | 3.06M |
| AccuStem Sciences | 3.05M |
| CASI Pharmaceuticals | 2.65M |
| Bioxytran | 2.50M |
| VitaSpring Biomedical | 2.30M |